Artiva Biotherapeutics, Inc. ARTV

Set alert

Price alert · ARTV

All alert types
4.20 USD 0.00 +0.12%

As of Nov 3, 10:30 AM ET

Bid
4.19 × 1
Ask
4.20 × 1
4.20 Day range 4.25
2.96 52-week range 14.53
YTD
-2.21%
1 year
+11.27%
Open
4.24
Prev close
4.19
Mkt cap
205.34M
Vol
140.19K
Avg vol
634.63K
EPS
-3.23
P/E
0.00
Div yield
0.00%
More statistics
Low
4.20
High
4.25
Forward P/E
-3.18
Beta
0.00
Short ratio
20.47
Inst. own
89.07%
Dividend
0.00
Ex-div date
Earnings
Feb 11, 2025
50-d avg
11.60
200-d avg
11.88
1y target
21.25

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for ARTV has not been loaded yet. Try again in a moment.

Analyst view

Consensus: none

Price target (mean) 21.25 +406.6% upside
Target (low)
18.00
Target (mean)
21.25
Target (high)
23.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy4
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5
  • 1 month ago 5
  • 2 months ago 5

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ARTV analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.58-0.58 – -0.580.000.0%60.00K0.0%1
Next quarter0.000.00 – 0.000.000.0%00.0%0
Current year-5.08-5.08 – -5.080.000.0%270.40K0.0%1
Next year-2.61-2.61 – -2.61-5.08+48.6%0-100.0%1

Upgrades and downgrades

The latest rating changes

ARTV analyst upgrades and downgrades
DateFirmActionFromTo
Nov 13, 2024NeedhamReiteratedBuyBuy
Aug 30, 2024NeedhamReiteratedBuyBuy
Aug 13, 2024NeedhamInitiated—Buy
Aug 13, 2024WedbushInitiated—Outperform
Aug 13, 2024Cantor FitzgeraldInitiated—Overweight
Aug 13, 2024TD CowenInitiated—Buy
Aug 13, 2024JefferiesInitiated—Buy